These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26308299)

  • 21. French pharmacovigilance: Missions, organization and perspectives.
    Vial T
    Therapie; 2016 Apr; 71(2):143-50. PubMed ID: 27080832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacovigilance in Germany : It is about time].
    Douros A; Schaefer C; Kreutz R; Garbe E
    Internist (Berl); 2016 Jun; 57(6):616-23. PubMed ID: 27224991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The credibility of the FDA.
    Blankfield RP
    Eur J Prev Cardiol; 2013 Dec; 20(6):992-4. PubMed ID: 23867140
    [No Abstract]   [Full Text] [Related]  

  • 24. Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar.
    Al Hail M; Elkassem W; Hamad A; Abdulrouf P; Thomas B; Stewart D
    Int J Clin Pharm; 2018 Aug; 40(4):769-774. PubMed ID: 29616393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role and strategy of ISoP in global pharmacovigilance.
    Olsson S; Harrison-Woolrych M
    Int J Clin Pharm; 2018 Aug; 40(4):740-743. PubMed ID: 30073610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records.
    Liu F; Jagannatha A; Yu H
    Drug Saf; 2019 Jan; 42(1):95-97. PubMed ID: 30649734
    [No Abstract]   [Full Text] [Related]  

  • 27. An historical overview over Pharmacovigilance.
    Fornasier G; Francescon S; Leone R; Baldo P
    Int J Clin Pharm; 2018 Aug; 40(4):744-747. PubMed ID: 29948743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacovigilance: Importance, concepts, and processes.
    Kumar A
    Am J Health Syst Pharm; 2017 Apr; 74(8):606-612. PubMed ID: 28235869
    [No Abstract]   [Full Text] [Related]  

  • 29. Measuring the impact of the 2012 European pharmacovigilance legislation on additional risk minimization measures.
    Francisca RDC; Zomerdijk IM; Sturkenboom MCJM; Straus SMJM
    Expert Opin Drug Saf; 2018 Oct; 17(10):975-982. PubMed ID: 30107752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of the National pharmacovigilance system in Malta - implementing and operating a pharmacovigilance management system.
    Tanti A; Micallef B; Serracino-Inglott A; Borg JJ
    Expert Opin Drug Saf; 2017 Jan; 16(1):65-76. PubMed ID: 27732110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff.
    Pirmohamed M
    Wien Klin Wochenschr; 2010 Feb; 122(3-4):62-4. PubMed ID: 20213370
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse drug reactions in neonates: could we be documenting more?
    Hawcutt DB; O'Connor O; Turner MA
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):807-20. PubMed ID: 25225053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The new pharmacovigilance legislation in practice].
    Broekmans AW; Mol PG
    Ned Tijdschr Geneeskd; 2014; 158():A7129. PubMed ID: 24846112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Causality assessment in reports on adverse drug reactions. Algorithm of Spanish pharmacovigilance system].
    Aguirre C; García M
    Med Clin (Barc); 2016 Nov; 147(10):461-464. PubMed ID: 27450163
    [No Abstract]   [Full Text] [Related]  

  • 35. Problems encountered in the pharmacovigilance of violence and aggression.
    Prescrire Int; 2014 Jun; 23(150):154. PubMed ID: 25121149
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacoepidemiology and its input to pharmacovigilance.
    Faillie JL; Montastruc F; Montastruc JL; Pariente A
    Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causality assessment in pharmacovigilance: The French method and its successive updates.
    Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
    Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cross-sectional study of adverse drug reactions reporting among doctors of a private medical college in Bihar, India.
    Panja B; Bhowmick S; Chowrasia VR; Bhattacharya S; Chatterjee RN; Sen A; Sarkar M; Ram AK; Mukherjee PK
    Indian J Pharmacol; 2015; 47(1):126-7. PubMed ID: 25821329
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacovigilance and use of online health information.
    Masoni M; Guelfi MR; Conti A; Gensini GF
    Trends Pharmacol Sci; 2013 Jul; 34(7):357-8. PubMed ID: 23759353
    [No Abstract]   [Full Text] [Related]  

  • 40. Validation Rules as a First Step for Data Quality: Pharmacovigilance Application in Portugal.
    Costa B; Figueiredo B; Pinheiro V
    Stud Health Technol Inform; 2023 May; 302():382-383. PubMed ID: 37203696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.